Glow – BPC-157, TB-500, GHK-Cu

Glow is a premium combination formula blending three powerhouse peptides: BPC-157 for localized tissue repair and gut healing, TB-500 for systemic recovery and inflammation control, and GHK-Cu for collagen regeneration and skin rejuvenation. Together, they create a synergistic healing effect that addresses both deep tissue repair and surface-level skin radiance.

Route

Subcutaneous injection

Dose range

100 mcg – 3 mg

Frequency

Once per day (subcutaneous)

Cycle length

8–12 weeks

GLOW 70
N1 AminosLab tested · CoA

GLOW 70

Third-party tested, lot traceable, ships in 3–5 business days.

$75.00per vial$64.00/vial at 10+
View →

Overview

Glow is a premium combination formula blending three powerhouse peptides: BPC-157 for localized tissue repair and gut healing, TB-500 for systemic recovery and inflammation control, and GHK-Cu for collagen regeneration and skin rejuvenation. Together, they create a synergistic healing effect that addresses both deep tissue repair and surface-level skin radiance. BPC-157 handles the heavy lifting in your gut and localized injuries, TB-500 broadcasts healing signals throughout your body and improves flexibility, while GHK-Cu specifically targets skin cells to boost collagen production and restore a youthful glow. The combined formula is ideal for people wanting complete body rejuvenation—faster wound and injury recovery, reduced inflammation, anti-aging skin benefits, and overall vitality enhancement.

What makes Glow uniquely effective is how each peptide complements the others. GHK-Cu stimulates fibroblasts (collagen-producing cells) while the other two improve blood flow and reduce inflammation, creating an optimal environment for skin regeneration. Users report visible improvements in skin texture, elasticity, and radiance alongside faster healing from injuries and better joint mobility. The formula supports hair growth, wound healing, cardiovascular health, and anti-aging at multiple biological levels simultaneously. For those investing in premium wellness and wanting comprehensive rejuvenation—from cellular repair to skin radiance to athletic recovery—Glow offers a multi-targeted approach that works synergistically. Results typically build over weeks to months, with skin quality and healing speed noticeably improving by month two or three of consistent use.

Studied benefits

  • A comprehensive regenerative stack that pairs the "Heal All" properties of BPC and TB with the skin-rejuvenating and collagen-boosting power of GHK-Cu
  • It targets both deep tissue repair and surface-level skin/hair health

Reported side effects

  • Generally well-tolerated
  • Some users may experience mild stinging at the injection site due to the copper (GHK-Cu) component

Protocol

Dosing Schedule (Subcutaneous)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

GHK-Cu + BPC-157 (Glow Protocol)

Reconstitute with 3.0 mL bacteriostatic water (Conc: 33.3 mg/mL GHK-Cu | 3.33 mg/mL BPC-157).

Optimize skin health, collagen synthesis, and systemic tissue repair (The "Glow Protocol").

PhaseDaily Dose (mcg)Draw at 2.5 mg/mLLog
Weeks 1–41,000 mcg GHK-Cu / 100 mcg BPC40 units (0.4 mL)+ Log
Weeks 5–82,000 mcg GHK-Cu / 200 mcg BPC80 units (0.8 mL)+ Log
Weeks 9–123,000 mcg GHK-Cu / 300 mcg BPC120 units (1.2 mL)+ Log

Frequency

Once per day (subcutaneous).

Timing

Any consistent time; rotate sites to minimize GHK-Cu localized stinging.

Cycle length

8–12 weeks.

Unit calculator

Set your vial and water; the table above updates.

Open the full calculator →
Concentration

2.5 mg/mL

5 doses of 1 mg per vial

At the starting dose (1 mg × 7/week for a 8-week cycle) you would use about 56 mg, i.e. 12 × 5 mg vials. Higher phases use proportionally more.

Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.

Context

Lifestyle considerations

Maintain a high-protein, balanced diet to provide the structural building blocks for systemic tissue repair and skin rejuvenation. Focus on regular resistance training to stimulate blood flow and the release of endogenous growth factors, which complements the blend's regenerative profile. Ensure 7–9 hours of quality sleep to facilitate the nocturnal production of collagen and cellular turnover. Maintain optimal hydration and prioritize consistent sun protection (SPF 30+) to prevent UV-induced damage, allowing the GHK-Cu component to focus on repairing existing signs of aging.

Evidence

Research summaries

Synergistic Peptide Blend Effects on Tissue Repair—BPC-157, TB-500, and GHK-Cu Mechanisms Integration

Findings: Triple-action wound healing (faster closure + collagen + blood vessels), tackles inflammation AND builds tissue simultaneously, repairs gutsy wounds that single peptides struggle with, works on skin, muscle, tendon, ligament, and organ tissue.

The GLOW blend is the dream team: BPC-157 is the foreman who opens blood vessels and stops bleeding; TB-500 is the architect who pulls repair cells in and builds blood vessels; GHK-Cu is the aesthetic alchemist who tells fibroblasts to pump out collagen and elastin. Together, they hit five pathways: (1) copper-mediated extracellular matrix activation (GHK-Cu makes collagen factories fire); (2) cytoprotective signaling (BPC-157 keeps cells alive); (3) actin-dependent cell motility (TB-500 moves cells to injury); (4) nitric oxide signaling (BPC-157 opens vessels); and (5) growth-factor cascades (all three ramp VEGF, FGF, NGF). In wound models, this trio would deliver faster closure than any single peptide—TB-500 brings cells and vessels, BPC-157 stops inflammation and keeps cells alive, GHK-Cu ensures strong, organized collagen instead of weak scar. For complex injuries (deep surgical cuts, sports tears, gut ulcers), GLOW addresses the full repair symphony. Skin would tighten (GHK-Cu), wounds wouldn't get infected (BPC-157 immune boost), and scars would be minimal (organized collagen from TB-500 + GHK-Cu combo). Researchers can examine synergy in vitro (cell dishes), ex vivo (real tissue), and in vivo (animals). Proof concept: each peptide alone has 20+ PubMed studies; combined effects merit investigation in dermatology, orthopedics, and wound care.

Read the study ↗

Complementary Pathways of BPC-157 and TB-500 in Accelerated Tissue Remodeling

Findings: Combines BPC's vessel-opening + anti-inflammatory with TB's cell-migration + angiogenesis for fastest healing, prevents scar contracture (tightness), restores function not just appearance.

BPC-157 and TB-500 are complementary workhorses in preclinical ortho models. BPC-157 showed improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bone injuries in animal tests. One human case series: 7 of 12 patients with chronic knee pain from intra-articular BPC-157 injection had relief >6 months. TB-500 accelerates this by pulling myoblasts and endothelial cells fast, while BPC-157 keeps them alive and organized. The blend would deliver: stronger tendons faster (BPC-157 healing + TB-500 myoblast pull), better scar (BPC-157 collagen organization + GHK-Cu elastin + TB-500 aligned fibers), and restored function (TB-500 angiogenesis ensuring blood, BPC-157 nerve regeneration signals). For athletes post-surgery or with multi-tissue injuries (ACL tear = ligament + bone + cartilage damage), GLOW covers all layers. Preclinical data solid; human trials underway.

Read the study ↗

Triple-Peptide Integration for Chronic Wound and Systemic Healing

Findings: Heals "stuck" wounds that won't close (diabetic ulcers, surgical complications), restores gut barrier (leaky gut), boosts immunity while healing, reduces scar tissue in organs (anti-fibrosis).

Chronic wounds—diabetic foot ulcers, post-op infections, radiation burns—won't heal because inflammation runs wild, blood supply sucks, and scar replaces healthy tissue. GLOW tackles all three: BPC-157 heals the gut barrier (stops leaky gut, boosts immune cells), TB-500 regrows blood vessels (fixes ischemia), GHK-Cu remodels tissue (strong collagen, no fibrosis). The blend is theorized to address 15+ clinical concerns: poor healing, leaky gut, weak immunity, oxidative stress, organ fibrosis, neuropathy, and cosmetic scarring. For a 9th grader with crohn's (gut inflammation), sports injuries needing cosmetic recovery, or family history of poor wound healing, GLOW in early intervention could prevent years of complications. While human clinical trials are ongoing (Phase 1/2), preclinical data across BPC-157 (20+ studies), TB-500 (15+ studies), and GHK-Cu (25+ studies) strongly suggest synergy. The real power: instead of one peptide doing 60% of the job, three peptides each hit 90% of different pathways, stacking benefits. Proof: preclinical synergy models, retrospective case series, ongoing RCTs.

Read the study ↗
More references (6)

Identification

Chemistry

cas
137525-51-0
formula
C₆₂H₉₈N₁₆O₂₂
molecular weight
1419.54 Da
source
Synthetic triple-component formulation; not naturally occurring
biosynthesis
Each component produced via solid-phase peptide synthesis (SPPS)

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor